IIPR

IIPR
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $64.685M ▲ | $27.32M ▲ | $29.305M ▲ | 45.304% ▲ | $1.01 ▲ | $52.469M ▲ |
| Q2-2025 | $62.891M ▼ | $27.126M ▼ | $26.024M ▼ | 41.38% ▼ | $0.87 ▼ | $48.968M ▼ |
| Q1-2025 | $71.722M ▼ | $30.379M ▲ | $31.077M ▼ | 43.33% ▼ | $1.05 ▼ | $53.968M ▼ |
| Q4-2024 | $76.744M ▲ | $27.131M ▼ | $40.025M ▼ | 52.154% ▼ | $1.38 | $61.38M ▼ |
| Q3-2024 | $76.526M | $27.274M | $40.215M | 52.551% | $1.38 | $62.586M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $36.671M ▼ | $2.338B ▲ | $474.573M ▲ | $1.863B ▼ |
| Q2-2025 | $99.666M ▼ | $2.305B ▼ | $424.649M ▼ | $1.88B ▼ |
| Q1-2025 | $128.01M ▼ | $2.353B ▼ | $430.423M ▼ | $1.922B ▼ |
| Q4-2024 | $146.245M ▼ | $2.378B ▼ | $441.987M ▼ | $1.936B ▼ |
| Q3-2024 | $147.128M | $2.395B | $448.794M | $1.947B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $29.305M ▲ | $45.591M ▼ | $-109.664M ▼ | $1.078M ▲ | $-62.995M ▼ | $45.591M ▼ |
| Q2-2025 | $26.024M ▼ | $48.449M ▼ | $-5.756M ▲ | $-71.037M ▼ | $-28.344M ▼ | $48.449M ▼ |
| Q1-2025 | $31.077M ▼ | $54.242M ▼ | $-17.156M ▼ | $-55.321M ▲ | $-18.235M ▼ | $54.242M ▲ |
| Q4-2024 | $39.455M ▼ | $58.067M ▼ | $-3.565M ▼ | $-55.385M ▼ | $-883K ▼ | $40.625M ▼ |
| Q3-2024 | $40.215M | $64.869M | $6.402M | $-44.978M | $26.293M | $64.869M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, IIPR looks like a specialized REIT that has transitioned from rapid expansion to a more mature, steady phase. The business is profitable with high margins, a reasonably conservative balance sheet, and stronger free cash flow now that heavy investment has slowed. Its niche focus and early entry into cannabis-related industrial properties have created a clear competitive position, but they also tie its fortunes to a complex and still-evolving regulatory environment and a relatively narrow tenant base. The emerging push into life sciences introduces a new growth avenue and additional diversification, but also execution risk. The key story going forward is whether the company can balance stable cash generation from its existing cannabis portfolio with thoughtful, disciplined growth and diversification into other specialized real estate segments.
NEWS
November 3, 2025 · 5:00 PM UTC
Innovative Industrial Properties Reports Third Quarter 2025 Results
Read more
October 21, 2025 · 6:00 AM UTC
Innovative Industrial Properties Announces Third Quarter 2025 Earnings Release Date and Conference Call
Read more
October 6, 2025 · 8:49 AM UTC
Innovative Industrial Properties Announces New $100 Million Revolving Credit Facility to Support Strategic Growth
Read more
October 1, 2025 · 6:23 PM UTC
Innovative Industrial Properties Announces Closing of Initial Investment Into IQHQ
Read more
September 15, 2025 · 6:55 AM UTC
Innovative Industrial Properties Declares Third Quarter 2025 Dividends
Read more
About Innovative Industrial Properties, Inc.
https://www.innovativeindustrialproperti...Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $64.685M ▲ | $27.32M ▲ | $29.305M ▲ | 45.304% ▲ | $1.01 ▲ | $52.469M ▲ |
| Q2-2025 | $62.891M ▼ | $27.126M ▼ | $26.024M ▼ | 41.38% ▼ | $0.87 ▼ | $48.968M ▼ |
| Q1-2025 | $71.722M ▼ | $30.379M ▲ | $31.077M ▼ | 43.33% ▼ | $1.05 ▼ | $53.968M ▼ |
| Q4-2024 | $76.744M ▲ | $27.131M ▼ | $40.025M ▼ | 52.154% ▼ | $1.38 | $61.38M ▼ |
| Q3-2024 | $76.526M | $27.274M | $40.215M | 52.551% | $1.38 | $62.586M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $36.671M ▼ | $2.338B ▲ | $474.573M ▲ | $1.863B ▼ |
| Q2-2025 | $99.666M ▼ | $2.305B ▼ | $424.649M ▼ | $1.88B ▼ |
| Q1-2025 | $128.01M ▼ | $2.353B ▼ | $430.423M ▼ | $1.922B ▼ |
| Q4-2024 | $146.245M ▼ | $2.378B ▼ | $441.987M ▼ | $1.936B ▼ |
| Q3-2024 | $147.128M | $2.395B | $448.794M | $1.947B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $29.305M ▲ | $45.591M ▼ | $-109.664M ▼ | $1.078M ▲ | $-62.995M ▼ | $45.591M ▼ |
| Q2-2025 | $26.024M ▼ | $48.449M ▼ | $-5.756M ▲ | $-71.037M ▼ | $-28.344M ▼ | $48.449M ▼ |
| Q1-2025 | $31.077M ▼ | $54.242M ▼ | $-17.156M ▼ | $-55.321M ▲ | $-18.235M ▼ | $54.242M ▲ |
| Q4-2024 | $39.455M ▼ | $58.067M ▼ | $-3.565M ▼ | $-55.385M ▼ | $-883K ▼ | $40.625M ▼ |
| Q3-2024 | $40.215M | $64.869M | $6.402M | $-44.978M | $26.293M | $64.869M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, IIPR looks like a specialized REIT that has transitioned from rapid expansion to a more mature, steady phase. The business is profitable with high margins, a reasonably conservative balance sheet, and stronger free cash flow now that heavy investment has slowed. Its niche focus and early entry into cannabis-related industrial properties have created a clear competitive position, but they also tie its fortunes to a complex and still-evolving regulatory environment and a relatively narrow tenant base. The emerging push into life sciences introduces a new growth avenue and additional diversification, but also execution risk. The key story going forward is whether the company can balance stable cash generation from its existing cannabis portfolio with thoughtful, disciplined growth and diversification into other specialized real estate segments.
NEWS
November 3, 2025 · 5:00 PM UTC
Innovative Industrial Properties Reports Third Quarter 2025 Results
Read more
October 21, 2025 · 6:00 AM UTC
Innovative Industrial Properties Announces Third Quarter 2025 Earnings Release Date and Conference Call
Read more
October 6, 2025 · 8:49 AM UTC
Innovative Industrial Properties Announces New $100 Million Revolving Credit Facility to Support Strategic Growth
Read more
October 1, 2025 · 6:23 PM UTC
Innovative Industrial Properties Announces Closing of Initial Investment Into IQHQ
Read more
September 15, 2025 · 6:55 AM UTC
Innovative Industrial Properties Declares Third Quarter 2025 Dividends
Read more

CEO
Paul E. Smithers
Compensation Summary
(Year 2022)

CEO
Paul E. Smithers
Compensation Summary
(Year 2022)
Ratings Snapshot
Rating : A
Most Recent Analyst Grades

Roth MKM
Buy

Citizens Capital Markets
Market Perform

Wolfe Research
Peer Perform

Piper Sandler
Underweight

Compass Point
Sell
Grade Summary
Price Target
Institutional Ownership

BLACKROCK INC.
5.006M Shares
$247.555M

BLACKROCK, INC.
4.652M Shares
$230.037M

VANGUARD GROUP INC
4.266M Shares
$210.94M

STATE STREET CORP
1.613M Shares
$79.745M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
516.841K Shares
$25.558M

INVESCO LTD.
440.364K Shares
$21.776M

GOLDMAN SACHS GROUP INC
403.555K Shares
$19.956M

D. E. SHAW & CO., INC.
388.129K Shares
$19.193M

ETF MANAGERS GROUP, LLC
377.796K Shares
$18.682M

NORTHERN TRUST CORP
361.475K Shares
$17.875M

BANK OF NEW YORK MELLON CORP
343.758K Shares
$16.999M

DIMENSIONAL FUND ADVISORS LP
333.941K Shares
$16.513M

MORGAN STANLEY
313.202K Shares
$15.488M

MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.
304.527K Shares
$15.059M

ALPHACORE CAPITAL LLC
211.407K Shares
$10.454M

LEGAL & GENERAL GROUP PLC
171K Shares
$8.456M

PRINCIPAL FINANCIAL GROUP INC
166.791K Shares
$8.248M

JPMORGAN CHASE & CO
150.623K Shares
$7.448M

PACER ADVISORS, INC.
145.366K Shares
$7.188M

THRIVENT FINANCIAL FOR LUTHERANS
134.687K Shares
$6.66M
Summary
Only Showing The Top 20

